Seizert Capital Partners LLC decreased its holdings in shares of CRH Medical Corp (NYSEAMERICAN:CRHM) by 7.6% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 157,937 shares of the company’s stock after selling 12,905 shares during the period. Seizert Capital Partners LLC’s holdings in CRH Medical were worth $479,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds have also modified their holdings of CRHM. Pacific Ridge Capital Partners LLC grew its position in shares of CRH Medical by 12.9% during the 1st quarter. Pacific Ridge Capital Partners LLC now owns 2,076,648 shares of the company’s stock valued at $5,524,000 after acquiring an additional 237,175 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp bought a new stake in shares of CRH Medical during the 1st quarter valued at $236,000. Finally, Wedge Capital Management L L P NC grew its position in shares of CRH Medical by 25.7% during the 1st quarter. Wedge Capital Management L L P NC now owns 118,903 shares of the company’s stock valued at $316,000 after acquiring an additional 24,347 shares during the period.
A number of equities research analysts have recently issued reports on CRHM shares. Bloom Burton raised shares of CRH Medical from an “accumulate” rating to a “buy” rating in a research report on Thursday, August 1st. Zacks Investment Research raised shares of CRH Medical from a “sell” rating to a “hold” rating in a research report on Monday, August 19th. One research analyst has rated the stock with a hold rating and three have given a buy rating to the stock. CRH Medical presently has an average rating of “Buy” and a consensus price target of $3.25.
CRH Medical (NYSEAMERICAN:CRHM) last issued its earnings results on Wednesday, July 31st. The company reported $0.02 earnings per share for the quarter, topping the consensus estimate of $0.01 by $0.01. The firm had revenue of $30.48 million during the quarter, compared to the consensus estimate of $29.50 million.
CRH Medical Profile
CRH Medical Corporation provides various products and services to gastroenterologists in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid. The company also offers anesthesia services for patients undergoing endoscopic procedures.
Recommended Story: How much money do you need to begin day trading?
Want to see what other hedge funds are holding CRHM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CRH Medical Corp (NYSEAMERICAN:CRHM).
Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.